Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 14.290 | 14.290 | 0.000 |
Shares | 87.810 | 87.810 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.051 | 24.124 |
Price to Book | 2.146 | 3.013 |
Price to Sales | 0.962 | 3.867 |
Price to Cash Flow | 11.966 | 15.880 |
Dividend Yield | 3.099 | 1.889 |
5 Years Earnings Growth | 10.430 | 13.292 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 97.380 | 95.436 |
Consumer Cyclical | 2.620 | 1.238 |
Number of long holdings: 43
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shenzhen Mindray Bio-Medical | CNE100003G67 | 9.89 | 270.68 | -2.14% | |
Jiangsu Hengrui | CNE0000014W7 | 8.51 | 47.70 | -1.55% | |
Jointown Pharm | CNE100000W45 | 7.23 | 5.39 | -2.53% | |
Humanwell Healthcare | CNE000000QW6 | 5.99 | 23.50 | +3.75% | |
Shenzhen YHLO Biotech Co | CNE100005204 | 5.14 | 18.28 | -1.51% | |
WuXi AppTec | CNE1000031K4 | 4.83 | 52.87 | -2.81% | |
Nhwa Pharma A | CNE100000CG8 | 4.27 | 26.56 | +2.15% | |
New Industries | CNE100003T39 | 2.93 | 67.79 | -1.25% | |
Chongqing Zhifei Bio Products | CNE100000V20 | 2.72 | 29.53 | -4.37% | |
Yunnan Baiyao A | CNE0000008X7 | 2.58 | 58.94 | -0.86% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Morgan Stanley Huaxin Multiple Fact | 607.16M | -6.97 | -11.05 | 4.55 | ||
MS Huaxin Resource Selected Mixed | 449.42M | 13.83 | -15.57 | 3.81 | ||
MS Huaxin Aggressive Growth Equity | 375.88M | 4.01 | -12.66 | 5.77 | ||
Huaxin Leading Advanced Stock | 311.33M | 2.09 | -9.58 | 8.39 | ||
MS Huaxin Quality Life Sec inv | 283.97M | 1.04 | -9.77 | 10.71 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review